Eli Lilly & Co. (NYSE:LLY) - Page 2

white pills

Pharma Stocks Crushed Under Election Rhetoric, but Top Analysts Say Buy These 4 Now

One thing you can always count on do-nothing politicians to employ is hot populist rhetoric on subjects that they won’t do anything about, but that they know strikes a chord ...
Read Full Story »
Carnival cruise ship

Baby Boomers Retiring and Spending Big: 5 Companies May Benefit Huge

The baby boomer generation was between 1946 and 1964 and turned into a huge influence on our society. Now with many retiring and others right behind them, they are also ...
Read Full Story »
Prescription drugs

What to Look for When Eli Lilly Reports Earnings

Eli Lilly and Co. (NYSE: LLY) plans to release its most recent earnings report before the markets open on Tuesday. The consensus estimates from Thomson Reuters are $0.95 in earnings ...
Read Full Story »
Unhealthy Person

Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma

Alkermes PLC (NASDAQ: ALKS) just announced positive Phase 3 results for its novel antidepressant ALKS 5461, and it’s serving as a rising tide — a storm surge even — for many biotech ...
Read Full Story »
aluminum cans

Merrill Lynch Makes a Big New Addition to the US 1 List

With earnings reports for the third quarter underway, and the fourth quarter of 2016 in full swing, many of the top companies we follow on Wall Street are making some ...
Read Full Story »
Medicine pills

Top 5 Jefferies Big Pharma Stock Picks for Q4

With major mergers and acquisition deals happening, and a host of clinical trials that could offer some outstanding breakthrough drug treatments, the big pharmaceutical stocks have had their fair share ...
Read Full Story »
buy now

4 Merrill Lynch US 1 Stocks to Buy That Also Pay Solid Dividends

This time last year the market was in trouble, having the first down year in some time. One spin around the sun and we are in much better shape as ...
Read Full Story »

Eli Lilly Expands Pet Vaccines Portfolio With Boehringer Acquisition

Eli Lilly and Co. (NYSE: LLY) shares had a bit of a boost on Wednesday after it was announced that one of its subsidiaries would be acquiring Boehringer Ingelheim Vetmedica (BIVI). Effectively, this ...
Read Full Story »
Statue of Liberty

Merrill Lynch Out With 10 Top US Stock Ideas for Q4

As incredible as it may seem, we are already into October, as the last quarter of 2016 is upon us. In a year that has shown some big volatility, the ...
Read Full Story »
Medicine pills

SunTrust Has Large Cap Dividend Pharma Stocks to Buy Now

Despite the political uproar over some pharmaceutical pricing, the fact of the matter is that once the political cycle is over, it’s entirely possible a lot of the rhetoric and ...
Read Full Story »
pet cat

2 Animal Health Stocks Still Look Attractive for Investors

If there is one trend that has worked in America, it is the trend of betting on the public taking care of their pets. Now Merrill Lynch has issued a ...
Read Full Story »
Light Switch

Merrill Lynch Makes a Huge Change to Prestigious US 1 Portfolio

With earnings for the third quarter on deck, and the fourth quarter of 2016 almost underway, many of the top companies we follow on Wall Street are making some changes ...
Read Full Story »
clinical trials

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to drive them forward. One key analyst issued a few of its top picks ...
Read Full Story »
Procter & Gamble

4 Safe Large Cap Dividend Stocks to Buy as Market Risk Increases

Friday reminded everybody of just how long we have a gone without a 1% or greater sell-off, and the volatility has jumped big time. Of course the big scare that ...
Read Full Story »
bull and bear

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

It is sometimes hard to wonder about health care and pharmaceutical stocks during an election year. Still, with uncertainty can come opportunity. The team at Credit Suisse has issued its ...
Read Full Story »